The findings, published in Pediatrics, support wider use of COVID-19 vaccine boosters in young people, the authors said. “COVID-19 vaccines in general have had very strong effectiveness,” said lead author Nicola Klein, MD, PhD, director of the Kaiser Permanente Vaccine Study Center, part of the Kaiser Permanente Division of Research. Teens (aged 12 and over) began receiving the Pfizer/BioNTech vaccine in August 2021, and children in June 2022. Additional Kaiser Permanente Division of Research co-authors were Ned Lewis, MPH, Kristin Goddard, MPH, Bruce Fireman, MA, and Ousseny Zerbo, PhD. # # #About the Kaiser Permanente Division of ResearchThe Kaiser Permanente Division of Research conducts, publishes and disseminates epidemiologic and health services research to improve the health and medical care of Kaiser Permanente members and society at large.

Source: Wall Street Journal April 08, 2023 02:41 UTC